Citation Impact
Citing Papers
Biomedically-relevant metal organic framework-hydrogel composites
2023 StandoutNobel
The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype
2001 Standout
Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials
2013 Standout
Pharmacokinetic and pharmacodynamic evaluation of a novel in situ forming poly(ethylene glycol)-based hydrogel for the controlled delivery of the camptothecins
2006
From traditional Chinese medicine to rational cancer therapy
2007 Standout
CLINICAL STUDIES OF CAMPTOTHECIN AND DERIVATIVES
2003
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
A Dose-Escalating Study of Weekly Bolus Topotecan in Previously Treated Ovarian Cancer Patients
2001
Clinical Pharmacokinetics of Topotecan
1996
The Imperative to Share Clinical Study Reports: Recommendations from the Tamiflu Experience
2012
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
Rethinking credible evidence synthesis
2012
Antioxidant activity and phenolic compounds of 112 traditional Chinese medicinal plants associated with anticancer
2004 Standout
Simultaneous determination of the lactone and carboxylate forms of the camptothecin derivative CPT-11 and its metabolite SN-38 in plasma by high-performance liquid chromatography
1998
Quantitation of camptothecin and related compounds
2001
Clinical applications of the camptothecins
1998
Analysis of anticancer drugs: A review
2011 Standout
Determination of camptothecin analogs in biological matrices by high-performance liquid chromatography
2000
<p>Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics</p>
2019 Standout
The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats
2007
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
2003 Standout
Primary brain tumours in adults
2012 Standout
Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children
2012
A Computationally Designed Hemagglutinin Stem-Binding Protein Provides In Vivo Protection from Influenza Independent of a Host Immune Response
2016 StandoutNobel
Natural compounds for cancer treatment and prevention
2009 Standout
Restoring invisible and abandoned trials: a call for people to publish the findings
2013
Continuous quality improvement in nephrology: a systematic review
2016
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
2001 Standout
Analytical approaches for traditional Chinese medicines exhibiting antineoplastic activity
2001
Topoisomerase I inhibitors: camptothecins and beyond
2006 Standout
Antibiotic Pharmacokinetics in Cystic Fibrosis
1987
Cancer of the Ovary
2004 Standout
Industry sponsorship and research outcome
2012 Standout
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
Risk of bias in industry-funded oseltamivir trials: comparison of core reports versus full clinical study reports
2014
Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins.
2002
Separation methods for camptothecin and related compounds
2001
The Overview on Effectiveness of Quality Enhancement for Enhancing Health Care and Professional Practice
2024 Standout
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
2012 Standout
Neuraminidase inhibitors for preventing and treating influenza in adults and children
2014
Protracted Intermittent Schedule of Topotecan in Children With Refractory Acute Leukemia: A Pediatric Oncology Group Study
2002
Increased Oral Bioavailability of Topotecan in Combination With the Breast Cancer Resistance Protein and P-Glycoprotein Inhibitor GF120918
2002
Protracted Intermittent Schedule of Topotecan in Children With Refractory Acute Leukemia: A Pediatric Oncology Group Study
2002
A phase I clinical trial of sequentially administered doxorubicin and topotecan in refractory solid tumors.
2002
Mathematics – Key Technology for the Future
2008 Standout
Phenytoin alters the disposition of topotecan and N-desmethyl topotecan in a patient with medulloblastoma.
1998
Industry sponsorship and research outcome
2017 Standout
Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line.
1999
Works of B. E. Davies being referenced
Phase I clinical and pharmacokinetic study of topotecan administered by a 24-hour continuous infusion.
1995
High-performance liquid chromatographic determination of the novel antitumour drug topotecan and topotecan as the total of the lactone plus carboxylate forms, in human plasma
1995
Safety and pharmacokinetics of oseltamivir at standard and high dosages
2010
Pharmacokinetics of ticarcillin in man
1982
Evaluation of a collaborative chronic care approach to improve outcomes in kidney transplant recipients
2013